STAT Plus: A longtime health care investor recalls the insulin bong, praises discipline in valuations, and looks to South America
"Back in the ’90s, biotech investing was the Wild West. We didn't have the sophisticated scientist folks creating companies or analyzing companies."
No hay comentarios:
Publicar un comentario